Bioengineering Progress in Lung Assist Devices
نویسندگان
چکیده
منابع مشابه
Basic knowledge of interest Bioengineering of liver assist devices
urine. Hepatocytes, which are the predominant cell type within the liver, account for two-thirds of the liver mass. The liver is normally able to regenerate after acute injury and regain its function under appropriate physiological stimuli.1 However, when the normal regenerative process is compromised and the residual functional capacity of the damaged liver is unable to sustain life, liver fai...
متن کاملBioengineering-blueprint for progress.
1 Acting Director, Prosthetic and Sensory Aids Service, U.S. Veterans Administration, Washington 25, D.C. THE limbs of m a n move in space and t ime, in response to systems of internal and external forces, and in accordance wi th the laws of mechanics. To restore to any satisfactory extent the functions lost through amputa t ion of an ext remi ty therefore requires in t imate knowledge not only...
متن کاملCost of ventricular assist devices: can we afford the progress?
T he societal cost of heart failure (HF) is matched by few other medical conditions. More than 670 000 new cases will be diagnosed this year. 1 It commonly affects the aged and is associated with other chronic illnesses. Despite significant improvements in outcomes associated with contemporary medical and electric therapies, HF tends to be a progressive condition with a median survival of only ...
متن کاملBioengineering for Organ Transplantation: Progress and Challenges.
Organ transplantation can offer a curative option for patients with end stage organ failure. Unfortunately the treatment is severely limited by the availability of donor organs. Organ bioengineering could provide a solution to the worldwide critical organ shortage. The majority of protocols to date have employed the use of decellularization-recellularization technology of naturally occurring ti...
متن کاملFunctional vascularized lung grafts for lung bioengineering
End-stage lung disease is the third leading cause of death worldwide, accounting for 400,000 deaths per year in the United States alone. To reduce the morbidity and mortality associated with lung disease, new therapeutic strategies aimed at promoting lung repair and increasing the number of donor lungs available for transplantation are being explored. Because of the extreme complexity of this o...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Bioengineering
سال: 2021
ISSN: 2306-5354
DOI: 10.3390/bioengineering8070089